Skip to main content
    C

    Climb Bio Inc (CLYM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.94
    -0.42 (-4.05%)

    Market Cap: $608.53M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Climb Bio Inc (CLYM) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Climb Bio reported EPS of -$0.18, above the -$0.20 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    53%(10/19)
    Avg Surprise
    +9.35%
    Streak
    3 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.21
    Range-$0.25 - -$0.19
    18 analysts
    Revenue Consensus
    N/A
    RangeN/A
    17 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-$0.23
    Range-$0.28 - -$0.20
    5 analysts
    EPS Revisions
    3
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.23+3.1%
    60d ago-$0.23+3.1%
    30d ago-$0.23+3.1%
    7d ago-$0.23+3.4%
    Current-$0.23
    Revenue Consensus
    N/A
    RangeN/A
    9 analysts

    Next Report

    CLYM's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 19 quarters below that had an estimate, CLYM beat 10, missed 8 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2021, when EPS landed 298.41% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.18-$0.20-$0.23 - -$0.16+10.00%BeatN/A101 up, 0 downNov 5, 2026
    Jun 30, 2026-$0.18-$0.22-$0.27 - -$0.18+18.18%BeatN/A8N/AAug 6, 2026
    Mar 31, 2026-$0.20-$0.30-$0.57 - -$0.25+33.33%BeatN/A80 up, 2 downMay 7, 2026
    Dec 31, 2025-$0.26-$0.19-$0.23 - -$0.19-38.89%Miss-750.0%30 up, 0 downMar 5, 2026
    Sep 30, 2025-$0.19-$0.15-$0.15 - -$0.14-26.67%MissN/A20 up, 0 downNov 6, 2025
    Jun 30, 2025-$0.13-$0.18N/A+27.78%BeatN/AN/A0 up, 0 downAug 12, 2025
    Mar 31, 2025-$0.31-$0.15N/A-106.67%MissN/AN/AN/AMay 14, 2025
    Dec 31, 2024$0.04-$0.15N/A+126.67%BeatN/AN/AN/AMar 25, 2025
    Sep 30, 2024-$0.13N/AN/AN/AN/AN/AN/AN/ANov 12, 2024
    Jun 30, 2024-$1.81N/AN/AN/AN/AN/AN/AN/AAug 14, 2024
    Mar 31, 2024-$0.06N/AN/AN/AN/AN/AN/AN/AMay 15, 2024
    Dec 31, 2023-$0.13-$0.13N/A-1.08%MissN/AN/AN/AMar 4, 2024
    Sep 30, 2023-$0.15-$0.14N/A-4.71%MissN/AN/AN/ANov 6, 2023
    Jun 30, 2023-$0.19-$0.16N/A-21.56%MissN/AN/AN/ASep 11, 2023
    Mar 31, 2023-$0.84-$0.25N/A-236.00%MissN/AN/AN/AMay 11, 2023
    Dec 31, 2022-$0.29-$0.33N/A+12.12%Beat-123.2%N/AN/AMar 31, 2023
    Sep 30, 2022-$0.37-$0.43N/A+13.95%BeatN/AN/AN/ANov 14, 2022
    Jun 30, 2022-$0.56-$0.47N/A-19.15%MissN/AN/AN/AAug 15, 2022
    Mar 31, 2022-$0.50-$0.50N/A0.00%In lineN/AN/AN/AMay 16, 2022
    Dec 31, 2021$1.25-$0.63N/A+298.41%BeatN/AN/AN/AMar 31, 2022
    Sep 30, 2021-$0.70-$0.85N/A+17.65%BeatN/AN/AN/ANov 8, 2021
    Jun 30, 2021-$0.61-$2.37N/A+74.26%BeatN/AN/AN/AJul 16, 2021
    Last 22 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.89, after -$1.96 the year before. It was -$0.06 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.89N/A
    Dec 31, 2024-$1.96N/A
    Dec 31, 2023-$1.31N/A
    Dec 31, 2022-$1.72N/A
    Dec 31, 2021-$0.06N/A

    Frequently Asked Questions About CLYM

    Did CLYM beat earnings estimates last quarter?

    Yes. Climb Bio reported EPS of -$0.18 for the quarter ended Sep 30, 2026, above the -$0.20 estimate, a 10.00% surprise.

    What EPS do analysts expect from CLYM next quarter?

    The consensus EPS estimate for Climb Bio for the quarter ending Dec 31, 2026 is -$0.21 from 18 analysts, with estimates from -$0.25 to -$0.19.

    How often does CLYM beat earnings estimates?

    Climb Bio beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +5.47%.